Condition: Enlarged Prostate

What It Is

An enlarged prostate is the ordinary, non-cancerous growth of the prostate gland that comes with age, and its medical name is benign prostatic hyperplasia. The prostate is a walnut-sized gland that sits just below the bladder and wraps around the urethra, the tube that carries urine out. As the gland grows it presses on that tube and stiffens the bladder-neck muscle around it, so the stream weakens. That produces the day-to-day symptoms, together called lower urinary tract symptoms:

• a weak or stop-start stream
• hesitancy before it begins
• going more often, with a sudden urge
• dribbling at the end
• waking at night to urinate
• a sense the bladder never fully empties

The enlargement is common and rises with each decade of life, and it is benign. It is not cancer and does not turn into cancer, though a man can have both at once. Prostate cancer, the PSA blood test, and whether to be screened are covered on Prostate Health.

How much the symptoms bother you matters more than how big the gland is, and there is a simple way to put a number on it. The IPSS is a seven-question form that scores urinary symptoms from 0 to 35 and sorts them into mild (0 to 7), moderate (8 to 19), and severe (20 to 35). It measures bother, not gland size, so two men with prostates of very different size can score the same, and the same score can come from an overactive bladder or an infection.

Filling it in before an appointment gives you and a clinician a shared number to track over time. A mild score usually means there is no rush; a moderate or severe score that disrupts your day is the point where treatment is worth starting.

What Helps

Most of what eases an enlarged prostate you can begin yourself, and for mild symptoms that is often enough. Watchful waiting means regular review with treatment held in reserve, and in the trial that set it against surgery most men who waited stayed stable, which makes it a legitimate plan for the bother-driven middle of the condition. Alongside it, a few habits reduce the bother and the risk of a sudden blockage, cost nothing, and pair with any medication later:

• Shift most of your fluids earlier in the day and ease off in the two or three hours before bed, which cuts the nighttime waking that bothers men most. Drinking too little makes things worse, though, since concentrated urine irritates the bladder.
• Ease back on caffeine and alcohol, both of which increase how much urine you make and irritate the bladder, so an evening coffee or a few drinks make a stream and a night worse.
• Take unhurried time on the toilet and try double voiding, waiting a moment after you finish and going again, which helps empty the bladder more fully.
• Check cold and allergy labels for decongestants such as pseudoephedrine and phenylephrine. They tighten the bladder-neck muscle and can worsen the stream, and in a man with an already narrowed outlet they can trigger a complete blockage.

When symptoms are bothersome, two classes of medication are well established, and they do different jobs. Alpha-blockers such as tamsulosin or silodosin relax the muscle around the prostate and bladder neck and ease the stream within days to weeks, so they are the usual first medication when a poor stream is the main complaint. They ease symptoms; they do not shrink the gland.

The 5-alpha-reductase inhibitors finasteride and dutasteride work on the gland itself. They block the hormone that drives prostate growth and shrink an enlarged gland over months, and they lower the chance of a sudden blockage and of needing surgery. They suit a large gland, take months to act, and halve the measured PSA, so any PSA reading taken while on one has to be doubled to be read correctly. For a large prostate at high risk of progression, combining the two beats either alone: the alpha-blocker eases symptoms quickly while the gland-shrinking drug slows the growth. For a small gland or mild symptoms, a single drug usually does the job with fewer side effects.

The Research & Studies

Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.

Genitourinary

Alpha-blockers ease the stream within days to weeks and cut progression 39%Strong

In plain terms

Alpha-blockers such as tamsulosin relax the muscle around the prostate and bladder neck, easing the stream within days to weeks. In the large MTOPS trial they improved symptoms and cut the risk of the condition getting worse by about 39%.

In detail

In MTOPS, 3,047 men were randomized to placebo, doxazosin, finasteride, or both and followed a mean 4.5 years. Doxazosin cut overall clinical progression, defined as a rise of at least 4 points in the symptom score, acute retention, incontinence, renal insufficiency, or recurrent infection, by 39% against placebo, and improved symptoms significantly. Because these drugs relax smooth muscle rather than shrink the gland, relief comes fast, within days to weeks, which is what makes them the usual first choice when symptoms are the problem and the gland is not very large. The tradeoff is that on their own they did not reduce acute retention or surgery in this trial. The older non-selective agent doxazosin can lower blood pressure and cause dizziness on standing; the prostate-selective drugs tamsulosin and silodosin cause less of that but more abnormal ejaculation.

How to use it

An alpha-blocker is the usual starting medication when the main complaint is a poor stream and daily bother. Standing up slowly in the first days limits dizziness, and if you are due for cataract surgery, tell the eye surgeon you take one before they operate.

The study · 1

McConnell et al. (MTOPS), the long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia · N Engl J Med 2003;349(25):2387-2398

Counts once: this finding and 2 others here come from the same source, so they are one body of evidence, not separate confirmations.

5-alpha-reductase inhibitors shrink the gland over months and cut progression 34%Strong

In plain terms

Finasteride and dutasteride shrink an enlarged prostate over months. In MTOPS finasteride cut the risk of the condition getting worse by about a third and, unlike the alpha-blocker, lowered the chance of sudden retention and surgery, an effect that held up over six years in a follow-up study.

In detail

The 5-alpha-reductase inhibitors block conversion of testosterone to dihydrotestosterone, the hormone that drives prostate growth, so they shrink an enlarged gland rather than only relaxing muscle. In MTOPS finasteride reduced overall clinical progression by 34% against placebo and was, along with combination therapy, the arm that significantly reduced acute urinary retention and the need for invasive treatment. The PLESS study confirmed that the lower rate of retention and surgery persisted across six years. Because they act on gland size, they help most when the prostate is clearly large and take months, not days, to work, which is why they are often paired with an alpha-blocker for early relief. They also lower measured PSA by about half, a fact any clinician ordering a screening test needs to know.

How to use it

A 5-alpha-reductase inhibitor is the choice when the gland is large and the goal is to prevent retention or surgery, often started alongside an alpha-blocker so relief comes while the shrinkage catches up. Tell any clinician ordering a PSA that you take one, because the result has to be doubled to be read correctly.

The studies · 2

McConnell et al. (MTOPS), the long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia · N Engl J Med 2003;349(25):2387-2398

Roehrborn et al. (PLESS), sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years · J Urol 2004;171(3):1194-1198

Counts once: this finding and 2 others here come from the same source, so they are one body of evidence, not separate confirmations.

Combining the two drugs cut progression 66%, more than either aloneStrong

In plain terms

Taking an alpha-blocker and a gland-shrinking drug together works better than either alone for men with a larger prostate. In MTOPS the combination cut the risk of progression by two thirds, and a four-year trial of dutasteride plus tamsulosin found the same pattern.

In detail

MTOPS showed that combining doxazosin and finasteride reduced overall clinical progression by 66% against placebo, better than doxazosin (39%) or finasteride (34%) alone, because the two drugs work by different mechanisms: one relaxes muscle for fast relief, the other shrinks the gland to change the trajectory. The CombAT trial then tested dutasteride plus tamsulosin over four years in 4,844 men with prostates of at least 30 mL and higher risk of progression, and found combination therapy superior to either monotherapy for symptom improvement and better than tamsulosin at reducing acute urinary retention and BPH-related surgery. The benefit is concentrated in men with larger glands, and combination brings the side effects of both classes, so it suits men at higher risk of progression rather than everyone with symptoms.

How to use it

Combination therapy makes the most sense when the gland is enlarged and the aim is both quick relief and preventing retention or surgery. For a small gland or mild symptoms, a single drug usually does the job with fewer side effects.

The studies · 2

McConnell et al. (MTOPS), the long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia · N Engl J Med 2003;349(25):2387-2398

Roehrborn et al. (CombAT), the effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results · Eur Urol 2010;57(1):123-131

Counts once: this finding and 2 others here come from the same source, so they are one body of evidence, not separate confirmations.

Saw palmetto did not beat placebo, a 0.04-point difference out of 35Strong · no effect

In plain terms

The common advice to take saw palmetto for an enlarged prostate has not held up. In good placebo-controlled trials, including one that pushed the dose to three times standard, it worked no better than a dummy pill, and the current Cochrane review agrees.

In detail

Saw palmetto is the most popular prostate supplement and was long recommended as an alternative to prescription drugs. Better trials revised that. The STEP trial randomized 225 men to saw palmetto or placebo for a year and found a difference in the symptom score of 0.04 points out of 35, with no difference in flow rate, prostate size, or residual volume. The CAMUS trial then took 369 men up to three times the standard 320 mg daily dose and still found no benefit over placebo. The 2023 Cochrane review concludes Serenoa repens does not improve urinary symptoms compared with placebo. The early positive reports came from smaller, lower-quality studies, which is where the reputation was built.

How to use it

If saw palmetto is already part of a routine it is not dangerous, but it is not doing the work its reputation claims. Money and hope are better spent on the measures that do move symptoms, and on a conversation about the drugs proven to prevent retention and surgery.

The studies · 3

Franco et al., Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement (Cochrane review) · Cochrane Database Syst Rev 2023;6:CD001423

Barry et al. (CAMUS), effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial · JAMA 2011;306(12):1344-1351

Bent et al. (STEP), saw palmetto for benign prostatic hyperplasia · N Engl J Med 2006;354(6):557-566

Most men on watchful waiting stayed stable; 17% failed treatment over three years versus 8.2% with surgeryModerate · mixed

In plain terms

When symptoms are moderate and nothing urgent is going on, watching and waiting is a legitimate choice. In a trial that compared it with surgery, surgery relieved symptoms more and roughly halved the chance of things getting worse, but most men who waited stayed stable and only about a quarter later chose surgery.

In detail

This trial randomized 556 men with moderate symptoms and no compelling reason to operate to either transurethral resection of the prostate or watchful waiting, meaning regular review with treatment held in reserve. Over three years surgery cut the rate of treatment failure to 8.2% against 17% for watchful waiting and produced larger improvements in symptoms and bladder function. But watchful waiting was far from a failure: most of those men remained stable, their symptom scores improved somewhat on their own, and about 24% eventually chose surgery within the three years. The reading is that for the bother-driven middle of the condition, the timing of treatment is a preference, and delaying it costs little for many men, which is what makes watchful waiting an active plan of monitoring, not neglect.

How to use it

If symptoms are moderate and you can live with them, watchful waiting with periodic review is reasonable, and you keep every treatment option open. Surgery moves up the list when the symptoms bother you enough, or when retention, infection, or kidney effects appear.

The study · 1

Wasson et al., a comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia · N Engl J Med 1995;332(2):75-79

Decongestants, some antihistamines and opioids can worsen the stream or trigger retentionModerate · risk

In plain terms

Some everyday drugs can make an enlarged-prostate problem worse or even stop the flow entirely. The main ones are cold and allergy decongestants such as pseudoephedrine, some antihistamines and antispasmodics, and opioid painkillers.

In detail

A review of drug-induced urinary retention lays out the mechanisms and the main offenders. Sympathomimetics, the class that includes over-the-counter decongestants such as pseudoephedrine and phenylephrine, tighten the smooth muscle at the bladder neck and can tip a man with an already narrowed outlet into acute retention. Anticholinergics, found in some older antihistamines, antispasmodics, and bladder and mood drugs, weaken the bladder muscle so it cannot push urine past the obstruction. Opioids do both. The risk is concentrated in men who already have bladder outlet obstruction from an enlarged prostate, which is exactly the reader of this page, so the practical step is to read cold-and-flu labels and tell a pharmacist about the prostate before starting one.

How to use it

Before taking a cold or allergy remedy, check whether it contains a decongestant such as pseudoephedrine or phenylephrine, and ask a pharmacist for an alternative if you have an enlarged prostate. The same goes for strong antihistamines and any new anticholinergic or opioid.

The study · 1

Verhamme et al., drug-induced urinary retention: incidence, management and prevention · Drug Saf 2008;31(5):373-388

The urethral lift and water vapor therapy relieve symptoms while preserving ejaculationModerate

In plain terms

Newer office-based procedures can relieve symptoms without the sexual side effects of traditional surgery. The prostatic urethral lift pins the gland open and preserved ejaculation in its trial, and water vapor therapy shrinks tissue with steam and roughly halved symptom scores.

In detail

Between medication and full surgery sit several minimally invasive procedures. The prostatic urethral lift (UroLift) uses small implants to hold the enlarged lobes open; in a randomized sham-controlled trial of 206 men it improved symptoms and flow and preserved erectile and ejaculatory function, which sets it apart from resection. Water vapor thermal therapy (Rezum) injects steam to ablate obstructing tissue; a randomized trial of 197 men found it roughly halved symptom scores against a control procedure while preserving sexual function. Both are done under local or light anesthesia, often as day cases. They generally relieve symptoms somewhat less than transurethral resection but avoid much of its bleeding and its effect on ejaculation, and they suit smaller-to-moderate glands. How long the benefit lasts over many years is still being mapped.

How to use it

If medication is not enough but full surgery feels like too much, and preserving ejaculation matters to you, ask a urologist whether a prostatic urethral lift or water vapor therapy fits your gland size and anatomy. For a very large gland or severe obstruction, resection or enucleation still relieves symptoms the most.

The studies · 2

Roehrborn et al. (L.I.F.T.), the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia · J Urol 2013;190(6):2161-2167

McVary et al., minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study · J Urol 2016;195(5):1529-1538

Beta-sitosterol improved symptoms about 4.9 points and flow about 3.9 mL/s in short trialsEmerging

In plain terms

Beta-sitosterol has better short-term data than saw palmetto: a Cochrane review found it improved symptoms and flow over placebo. It has no long-term evidence, though, and it did not shrink the gland or show it can prevent complications.

In detail

A Cochrane review pooled 4 randomized, placebo-controlled trials of beta-sitosterol in 519 men lasting 4 to 26 weeks. It improved urinary symptom scores by a weighted mean of about 4.9 points and peak urine flow by about 3.9 mL per second, and reduced post-void residual volume, but did not reduce prostate size. The reviewers were explicit that long-term effectiveness, safety, and any ability to prevent BPH complications are unknown, because no trial ran long enough to test them. So there is a short-term signal sitting on old and brief studies, which is a narrower claim than these products are sold on.

How to use it

If a plant supplement is wanted, beta-sitosterol has more behind it than saw palmetto for short-term symptoms, but it is not a substitute for the drugs that prevent retention, and it should not be read as protecting the prostate over years, which was never tested.

The study · 1

Wilt et al., beta-sitosterols for benign prostatic hyperplasia (Cochrane review) · Cochrane Database Syst Rev 2000;(2):CD001043

Pygeum cut nocturia about a fifth and raised peak flow about 23% in short trialsEmerging

In plain terms

Pygeum, an extract of African plum-tree bark, has an older Cochrane review behind it showing modest improvement in urinary symptoms and flow. The trials were small and short and used inconsistent preparations, so it is a weak signal rather than settled evidence.

In detail

A Cochrane review pooled 18 randomized trials in 1,562 men of Pygeum africanum, extracted from the bark of the African plum tree. Men taking it were more than twice as likely to report improvement, with roughly 19% fewer nocturia episodes and about a 23% increase in peak urine flow compared with placebo. The catch is the quality: the trials were small, mostly ran only weeks, used a range of non-standardized extracts and doses, and none measured prostate size or long-term complications. So there is a consistent short-term signal, but it sits on dated, methodologically limited studies rather than the kind of large, rigorous trial that would settle it.

How to use it

Pygeum is one of the better-studied plant options for short-term symptoms, but the evidence is old and thin and it has not been shown to prevent retention or surgery. Treat it as a modest helper at most, not a replacement for the proven medications when those are indicated.

The study · 1

Wilt et al., Pygeum africanum for benign prostatic hyperplasia (Cochrane review) · Cochrane Database Syst Rev 2002;(1):CD001044

Measurement And Diagnosis

The IPSS scores urinary symptoms from 0 to 35, tracking bother not gland sizeModerate · mixed

In plain terms

The standard way to size up an enlarged-prostate problem is a seven-question form, the IPSS, that scores urinary symptoms from 0 to 35 and sorts them into mild, moderate, and severe. It tracks how much the symptoms bother you, not how big the gland is.

In detail

The American Urological Association symptom index, adopted worldwide as the International Prostate Symptom Score, asks seven questions about incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and waking at night to urinate, each scored 0 to 5 for a total of 0 to 35. In its validation it was internally consistent, stable on retest, and tracked the man's own rating of how much the symptoms bothered him, which is why it is used to decide who can watch and wait and to measure whether a treatment is working. It deliberately measures symptom burden rather than gland size, and the same score can come from overactive bladder or infection, so it guides the conversation rather than settling the diagnosis on its own.

How to use it

Filling in the IPSS before an appointment gives you and the clinician a shared number to track over time. A mild score usually means watchful waiting is reasonable; a moderate or severe score that bothers you is the point at which treatment is worth discussing.

The study · 1

Barry et al., the American Urological Association symptom index for benign prostatic hyperplasia · J Urol 1992;148(5):1549-1557

When medication is not enough, or the gland is very large, procedures come into the picture, and they now span a range. Office-based procedures, done under local or light anesthesia, sit between tablets and full surgery. The prostatic urethral lift pins the enlarged lobes open with small implants, and water vapor therapy uses steam to shrink obstructing tissue. Both relieve symptoms while preserving ejaculation, which sets them apart from traditional surgery, and they suit smaller-to-moderate glands.

For a large gland or symptoms that medication does not control, transurethral resection of the prostate (TURP) and, for very large glands, enucleation relieve the obstruction the most. The choice among all of these is one to weigh with a urologist against your gland size and your own priorities.

A sudden and complete inability to pass urine, with a full and painful bladder, is a same-day emergency: it will not clear on its own and needs a catheter to drain the bladder.

The Supplement and Herb Evidence

The supplement most men reach for first has the least behind it. Saw palmetto is the most tested prostate supplement and was recommended for years as an alternative to prescription drugs. The strong trials revised that:

• In the STEP trial the difference from a dummy pill on the symptom score was 0.04 points out of 35.
• The CAMUS trial pushed the dose to three times standard and still found nothing over placebo.
• The 2023 Cochrane review, pooling the higher-quality trials, concludes it gives little to no benefit.

It is not dangerous, so a man already taking it comes to no harm, but it is not doing the work its reputation claims, and money is better spent on the measures that move symptoms.

Two plant options show a modest short-term signal, on older and thinner evidence.

• Beta-sitosterol, a plant compound, improved symptom scores by about 4.9 points and peak urine flow by about 3.9 mL per second over placebo in a Cochrane review of four short trials, though it did not shrink the gland.
• Pygeum, an extract of African plum-tree bark, modestly improved symptoms and flow in a review of eighteen small trials, with about a fifth fewer nighttime trips and roughly a 23% rise in peak flow.

The limit is the same for both:

• the trials were small
• they ran only weeks
• they used inconsistent preparations
• none tested whether these products prevent the blockages and surgery that the prescription drugs are proven to prevent

So they are modest short-term helpers at most, not protection for the gland over years. Prostate products sold online also have a documented record of being adulterated with undeclared drugs, so anything herbal belongs with a traceable supply.

Go Deeper

• Prostate Health: the separate questions of prostate cancer, the PSA blood test, and whether to be screened.
• Erectile dysfunction: where the sexual side effects of these medications fit, and the blood-flow causes behind most erection trouble.
• Caffeine: how caffeine increases urine output and irritates the bladder, and how to time it.
• Testosterone therapy: why testosterone is checked against the prostate, and how it differs from the hormone that drives prostate growth.

The Chinese Medicine View

The Chinese Medicine View

Chinese medicine has no category called the prostate, and reads difficult or blocked urination through the organs of the lower burner, the region governing urination and reproduction. The classical name for a poor, dribbling, or obstructed stream is Long Bi (癃閉). Read the patterns below as an interpretive lens on how a man presents, not as a map of the gland or a substitute for measuring the flow and checking the bladder empties. Chinese medicine treats these pictures differently depending on presentation: the warming herbs that suit a cold, deficient Kidney picture are the wrong direction for a hot, damp one, and the aging that underlies most enlargement is read as an underlying deficiency that calls for tonifying. Herbal treatment belongs with a practitioner and a traceable supply, since prostate products sold online have a documented history of adulteration. The separate cancer and screening questions are not a Chinese medicine matter and sit on the prostate-health page.

Kidney deficiency (腎虛)

The terrain of aging that underlies most enlargement. Yang deficiency shows as a weak, dribbling stream, frequent pale urination, feeling cold, and low back and knee weakness; Yin deficiency as scanty dark urine, night sweats, and a dry mouth. The direction is to tonify the Kidneys, warming the Yang or nourishing the Yin as the picture shows.

Damp-heat in the lower burner (下焦濕熱)

Burning, urgent, frequent or difficult urination, sometimes cloudy urine or a heavy feeling below, with a yellow greasy tongue coat. This is the pattern most often mapped to irritation and infection rather than the enlargement itself. The direction is to clear heat and drain damp.

Qi stagnation and blood stasis (氣滯血瘀)

A stream that starts and stops, a sense of never quite emptying, and a fixed, distending discomfort low in the abdomen, on a dusky or purplish tongue. Long-standing obstruction is read as qi and blood no longer moving freely. The direction is to move qi and invigorate blood to open the flow.

Cautions With the Treatments

Extra restraint

Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.

A sudden and complete inability to pass urine is acute urinary retention, a same-day emergency

Acute urinary retention is a sudden inability to empty the bladder, typically with lower abdominal pain and a palpable full bladder, and an enlarged prostate is its most common cause in men. Guidelines, including a 2025 review, treat it as a urological emergency whose first step is immediate bladder drainage by catheter. Preventing it is one of the specific reasons a 5-alpha-reductase inhibitor is used long term, since finasteride and combination therapy lower the chance of it happening. Once it has occurred, though, it needs same-day care, because sustained retention raises pressure back through the urinary tract and can damage the bladder wall and the kidneys. Certain triggers, including some decongestants and a heavy alcohol session, can precipitate it in a man with an already narrowed outlet.Pinar et al., management of acute urinary retention in men with benign prostatic hyperplasia: literature review and guidelines

Alpha-blockers often reduce ejaculate, and tamsulosin can cause floppy iris in cataract surgery

Reduced or absent ejaculate is one of the most common effects of tamsulosin and silodosin, reported across the large BPH trials, and it reverses when the drug is stopped. Separately, tamsulosin is the alpha-blocker most tied to intraoperative floppy iris syndrome, where the iris billows and the pupil constricts during cataract surgery, raising the risk of complications. A prospective masked comparison graded the syndrome as more severe in men taking tamsulosin than in those on the less selective alfuzosin or on nothing. It can occur even in men who stopped the drug months earlier, which is why the safe step is to tell the eye surgeon before the operation rather than to stop the drug on your own.Roehrborn et al. (CombAT), the effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year resultsChang et al., prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin

The gland-shrinking drugs commonly lower libido and cause erectile difficulty, reversible for most men

A meta-analysis of 5-alpha-reductase inhibitor monotherapy in BPH found a statistically clear but small benefit over placebo, alongside a high rate of adverse events including reduced libido, erectile difficulty, and reduced ejaculate volume. For most men these ease over time or reverse when the drug is stopped. A separate analysis of medical records reported that a subset of men, more often younger men with longer exposure, developed erectile dysfunction that persisted after stopping, the basis of what some call post-finasteride syndrome. That persistent picture rests on observational data and its true frequency is disputed, so it belongs in the decision as a possibility to weigh rather than an established rate. This is the downside to weigh against the strong progression data, and the reason the choice is worth making deliberately.Kim et al., efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: a meta-analysisKiguradze et al., persistent erectile dysfunction in men exposed to the 5-alpha-reductase inhibitors finasteride or dutasteride

The gland-shrinking drugs halve the PSA reading

Finasteride and dutasteride lower the measured PSA by about half within several months, so a screening result taken while on one has to be roughly doubled to be read correctly. Tell any clinician ordering a PSA that you take one, since an unadjusted value can look reassuringly low when it is not.

Alpha-blockers can cause dizziness on standing at first

The older non-selective alpha-blockers in particular can lower blood pressure and cause light-headedness on standing in the first days, so standing up slowly helps while the body adjusts. The prostate-selective drugs tamsulosin and silodosin cause less of this. If you are due for cataract surgery, tell the eye surgeon you take one before they operate.

Most of living with an enlarged prostate is worked out steadily at your own pace, and the habits above are yours to start today. Which medication or procedure fits, and any change to one, is a conversation with the clinician who can weigh it with you.

When to See Someone

Most of living with an enlarged prostate is steady and worked out at your own pace. A few situations are different, and one rule sits above the rest: a sudden and complete inability to pass urine is a same-day emergency. These are the signs to get seen about:

• A sudden and painful inability to pass urine, with a full, tense bladder. This is acute urinary retention, a urological emergency that needs the bladder drained with a catheter that day, because it will not clear on its own and can harm the kidneys(seek urgent care)
• Fever together with painful, frequent or difficult urination, which can mean a urinary or prostate infection and needs prompt antibiotics rather than the measures for a benign enlarged prostate(seek urgent care)
• Visible blood in the urine. It often has a harmless cause, but because it can be the first sign of a bladder, kidney or prostate cancer it needs to be assessed(seek urgent care)
• Urinary symptoms that worsen quickly over days rather than the usual slow change over months
• Recurrent urinary infections, bladder stones, or a constant sense the bladder never empties, all of which point to obstruction that a urologist should assess
• Leaking urine because the bladder stays full and overflows, or new or worsening kidney results, both of which need prompt review
• A decision about which medication or procedure fits, and any question about a PSA test or cancer risk, which belongs with a doctor and is covered on the prostate-health page

None of this is a reason to worry about ordinary urinary symptoms, which are common and very treatable. The few signs to know are those that change the timeline, and a sudden complete blockage is the one emergency here. You can score your own symptoms with the IPSS and track them as you try things, and take any decision about medication or a procedure to the person who can weigh it with you.

Common Questions

Is an enlarged prostate the same as prostate cancer?

No. Benign prostatic hyperplasia is a non-cancerous enlargement of the gland, it does not turn into cancer, and having it does not mean cancer will follow, though a man can have both at the same time. The symptoms it causes come from the gland pressing on the urethra, not from a tumor. Prostate cancer, the PSA blood test, and whether to be screened are separate questions covered on the Prostate Health page.

How are the symptoms measured, and when is treatment worth it?

With the IPSS, a seven-question form that scores urinary symptoms from 0 to 35 and sorts them into mild (0 to 7), moderate (8 to 19), and severe (20 to 35). It tracks how much the symptoms bother you rather than the size of the gland, so it is the number used to decide who can watch and wait and to tell whether a treatment is working. A mild score usually means there is no rush; a moderate or severe score that disrupts your day is the point where treatment is worth discussing (Barry and colleagues, Journal of Urology, 1992).

Does saw palmetto help an enlarged prostate?

Not in the strong trials. In the STEP trial the difference from a dummy pill was 0.04 points out of 35 on the symptom score, the CAMUS trial found nothing even at three times the standard dose, and the 2023 Cochrane review concludes it gives little to no benefit. It is not dangerous, so a man already taking it comes to no harm, but it is not doing what its reputation claims (Bent and colleagues, New England Journal of Medicine, 2006; Franco and colleagues, Cochrane Database of Systematic Reviews, 2023).

What is the fastest way to ease the symptoms?

An alpha-blocker such as tamsulosin, which relaxes the muscle around the prostate and bladder neck and eases the stream within days to weeks. In the large MTOPS trial the alpha-blocker improved symptoms and cut the risk of the condition getting worse by 39%. These drugs relieve symptoms but do not shrink the gland, so for a large prostate they are often paired with a gland-shrinking drug that slows the growth over months (McConnell and colleagues, MTOPS, New England Journal of Medicine, 2003).

Do finasteride and dutasteride cause lasting sexual side effects?

For most men the sexual side effects, lower libido and erectile difficulty, ease over time or reverse when the drug is stopped, and a pooled analysis found the overall symptom benefit came with a meaningful rate of these effects. A minority of men, more often younger men on the drug longer, report problems that persist after stopping, though that picture rests on medical-record data and its true frequency is disputed. It is a possibility to weigh, not an established rate, and the way to handle it is to raise any lasting change with the prescriber early (Kim and colleagues, PLoS One, 2018; Kiguradze and colleagues, PeerJ, 2017).

What should I do if I suddenly cannot pass urine at all?

Treat it as an emergency and get to urgent care the same day. A sudden, painful inability to pass urine with a full, tense bladder is acute urinary retention, and an enlarged prostate is its most common cause in men. It does not clear on its own and needs the bladder drained with a catheter, because sustained retention raises pressure back through the urinary tract and can damage the bladder and kidneys (Pinar and colleagues, French Journal of Urology, 2025).